Adelaide graduated with a First Class (Hons) BSc degree in Pharmacology from King's College London in 2017. This included a final year research project investigating the toxic properties of Levodopa on human neuronal cells in the context of Parkinson's disease. She also gained one year industrial experience as part of a placement with Novartis Institute for Biomedical Sciences at their site in Emeryville, California. During this time, she worked within a multidisciplinary team with the aim of deciphering the role of Mecillinam pharmacokinetics in the ability to treat resistant E. coli infections. She presented the results of this research at the British Pharmacological Society meeting in 2016.
Adelaide joined the CDT in 2017 and undertook her first training project under the supervision of Dr Pavel Gershkovich, working on HPLC method development. For her second training project, Adelaide worked in Global Product Development at AstraZeneca, Macclesfield, where she was investigating the moisture protective capabilities of tablet coats.
Adelaide is currently in the first year of her PhD, investigating the Targeted Bio-distribution of Drugs to the Lymphatic System, under the supervision of Dr Pavel Gershkovich, Prof Peter Fischer and… read more
Adelaide is currently in the first year of her PhD, investigating the Targeted Bio-distribution of Drugs to the Lymphatic System, under the supervision of Dr Pavel Gershkovich, Prof Peter Fischer and Prof David Heery.
University of NottinghamUniversity Park
Nottingham, NG7 2RD
For all enquiries please visit:
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs
Browser does not support script.